医学
依维莫司
肾细胞癌
舒尼替尼
肿瘤科
内科学
临床研究阶段
泌尿科
临床试验
临床终点
随机对照试验
作者
Nizar M. Tannir,Eric Jonasch,Emre Altinmakas,Chaan S. Ng,Wei Qiao,Pheroze Tamboli,Priya Rao,David F. McDermott,Christopher G. Wood,Toni K. Choueiri
标识
DOI:10.1200/jco.2014.32.15_suppl.4505
摘要
4505 Background: In a single-arm phase II trial of sunitinib in non-clear cell RCC (nccRCC) we previously reported (Tannir et al. Eur Urol 2012), objective response rate [ORR] was 5% and median pro...
科研通智能强力驱动
Strongly Powered by AbleSci AI